What is DK Pierce?
DK Pierce & Associates, Inc. is dedicated to providing strategic reimbursement and market access solutions for cutting-edge therapies, with a focus on rare diseases, oncology, and cell and gene therapies. The employee-owned company offers bespoke consulting services encompassing commercialization, account management, and clinical strategy. Their expertise assists clients, primarily pharmaceutical companies, in successfully navigating the intricate pathways to market access for their novel products. DK Pierce emphasizes a people-first culture, fostering collaboration and community service, which translates into their client-centric approach to problem-solving in the healthcare industry.
How much funding has DK Pierce raised?
DK Pierce has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for DK Pierce?
The substantial late-stage funding and recent strategic investment position DK Pierce for accelerated growth and expanded service offerings. This capital infusion is expected to enhance their capabilities in supporting clients through the evolving reimbursement and market access challenges inherent in specialized therapeutic areas. The company's focus on employee ownership and collaborative culture suggests a strategic approach to talent acquisition and retention, crucial for maintaining their high-quality consulting services. Future developments will likely involve deepening their expertise in emerging fields like cell and gene therapies and further solidifying their market leadership in reimbursement strategy.
See full DK Pierce company page
